TipRanks
TME Pharma N.V. (DE:0N6A)
FRANKFURT:0N6A
Germany Market

TME Pharma N.V. (0N6A) Financial Statements

1 Followers

TME Pharma N.V. Financial Overview

TME Pharma N.V.'s market cap is currently €11.77M. The company's EPS TTM is €-0.0326; its P/E ratio is -3.55; TME Pharma N.V. is scheduled to report earnings on October 30, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 0.00€ 19.00K€ 17.00K€ 0.00€ 33.00K
Gross Profit€ -8.00K€ -78.00K€ -127.00K€ -92.00K€ -65.97K
Operating Income€ -2.91M€ -5.28M€ -5.62M€ -12.03M€ -13.27M
EBITDA€ -2.90M€ -5.17M€ -5.07M€ -11.63M€ -12.88M
Net Income€ -3.29M€ -5.72M€ -6.74M€ -15.13M€ -14.45M
Balance Sheet
Cash & Short-Term Investments€ 2.02M€ 3.25M€ 2.25M€ 4.63M€ 9.48M
Total Assets€ 2.14M€ 3.41M€ 2.49M€ 5.24M€ 9.77M
Total Debt€ 2.39M€ 56.00K€ 1.17M€ 4.09M€ 2.44M
Net Debt€ 376.00K€ -3.24M€ -1.08M€ -548.00K€ -7.02M
Total Liabilities€ 3.72M€ 1.79M€ 2.79M€ 6.51M€ 5.27M
Stockholders' Equity€ -1.58M€ 1.61M€ -294.00K€ -1.27M€ 4.51M
Cash Flow
Free Cash Flow€ -3.42M€ -4.65M€ -5.65M€ -12.16M€ -12.39M
Operating Cash Flow€ -3.42M€ -4.63M€ -5.63M€ -12.14M€ -12.38M
Investing Cash Flow€ 8.00K€ -21.00K€ -19.00K€ -21.00K€ -14.00K
Financing Cash Flow€ 2.18M€ 5.66M€ 3.27M€ 7.29M€ 11.50M
Currency in EUR

TME Pharma N.V. Earnings and Revenue History

TME Pharma N.V. Debt to Assets

TME Pharma N.V. Cash Flow

TME Pharma N.V. Forecast EPS vs Actual EPS